Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.

α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease

Open access

Abstract

A diagnosis of motor Parkinson’s disease (PD) is preceded by a prolonged premotor phase with accumulating neuronal damage. Here we examined the temporal relation between α-synuclein (α-syn) T cell reactivity and PD. A longitudinal case study revealed that elevated α-syn-specific T cell responses were detected prior to the diagnosis of motor PD, and declined after. The relationship between T cell reactivity and early PD in two independent cohorts showed that α-syn-specific T cell responses were highest shortly after diagnosis of motor PD and then decreased. Additional analysis revealed significant association of α-syn-specific T cell responses with age and lower levodopa equivalent dose. These results confirm the presence of α-syn-reactive T cells in PD and show that they are most abundant immediately after diagnosis of motor PD. These cells may be present years before the diagnosis of motor PD, suggesting avenues of investigation into PD pathogenesis and potential early diagnosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-020-15626-w

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 α-Syn-specific T cell responses in a longitudinal case study of PD. a Total magnitude of response expressed as total SFC (sum of IFNγ, IL-5, and IL-10 responses) per 106 cultured PBMC against a pool of α-syn peptides (furthest to the right) and all individual α-syn peptides included in the pool. Representative data from PBMC collected in 2006. b–d After eliminating non-lymphocytes and doublet cells by forward and side-scatter, and dead cells by Live/Dead stain, CD3+ T cells were gated based on their CD4 and CD8 expression (CD8+, CD8+CD4+, CD4+, CD8−CD4−), and other populations as indicated; CD3−CD19− and CD19+ (Supplementary Fig. 5), percentage cytokine of live cells from each of these were plotted. b IFNγ (n = 6), c IL-4 (n = 6), and d IL-10 (n = 3). Each point represents a sample collected between 1998 and 2015 (1998, 2005, 2006, 2007, 2013, and 2015); median ± interquartile range is indicated. e Total magnitude of response expressed as total SFC (sum of IFNγ, IL-5, and IL-10 responses) per 106 cultured PBMC against a pool of α-syn peptides or PHA. The time period spans 1998 (pre-2001) to 2018. Median ± interquartile range is indicative of individual experimental replicates. Pre- March-01 n = 10, Oct-05 n = 4, Jul-06 n = 3, Mar-07 n = 9, Apr-07 n = 3, May-07 n = 5, Oct-07 n = 1, Jan-13 n = 4, Aug-15 n = 12, and May-18 n = 2. f Total magnitude of response divided into pre- (1998–2006) (n = 17) and (2007–2008) (n = 18), which reflects the period this individual experienced shingles) and post- (2009–2018) (n = 18) PD onset/diagnosis for α-syn-specific responses (left) and PHA (right). Each point represents an individual independent experimental replicate; the median ± interquartile range is indicated. Two-tailed Mann–Whitney test. The data are displayed on a logarithmic scale.
Fig. 1 α-Syn-specific T cell responses in a longitudinal case study of PD. a Total magnitude of response expressed as total SFC (sum of IFNγ, IL-5, and IL-10 responses) per 106 cultured PBMC against a pool of α-syn peptides (furthest to the right) and all individual α-syn peptides included in the pool. Representative data from PBMC collected in 2006. b–d After eliminating non-lymphocytes and doublet cells by forward and side-scatter, and dead cells by Live/Dead stain, CD3+ T cells were gated based on their CD4 and CD8 expression (CD8+, CD8+CD4+, CD4+, CD8−CD4−), and other populations as indicated; CD3−CD19− and CD19+ (Supplementary Fig. 5), percentage cytokine of live cells from each of these were plotted. b IFNγ (n = 6), c IL-4 (n = 6), and d IL-10 (n = 3). Each point represents a sample collected between 1998 and 2015 (1998, 2005, 2006, 2007, 2013, and 2015); median ± interquartile range is indicated. e Total magnitude of response expressed as total SFC (sum of IFNγ, IL-5, and IL-10 responses) per 106 cultured PBMC against a pool of α-syn peptides or PHA. The time period spans 1998 (pre-2001) to 2018. Median ± interquartile range is indicative of individual experimental replicates. Pre- March-01 n = 10, Oct-05 n = 4, Jul-06 n = 3, Mar-07 n = 9, Apr-07 n = 3, May-07 n = 5, Oct-07 n = 1, Jan-13 n = 4, Aug-15 n = 12, and May-18 n = 2. f Total magnitude of response divided into pre- (1998–2006) (n = 17) and (2007–2008) (n = 18), which reflects the period this individual experienced shingles) and post- (2009–2018) (n = 18) PD onset/diagnosis for α-syn-specific responses (left) and PHA (right). Each point represents an individual independent experimental replicate; the median ± interquartile range is indicated. Two-tailed Mann–Whitney test. The data are displayed on a logarithmic scale.CC BY · PubMed Central
Fig. 2 Reactivity to α-syn in patients with PD or AD as compared with HC. Magnitude of responses a IFNγ, b IL-5, c IL-10, and d sum of IFNγ, IL-5, and IL-10 against the α-syn peptide pool as SFC per 106 cultured PBMC. Each point represents one participant. Closed circles, patients with PD (n = 77); open circles, controls (n = 69). One-tailed Mann–Whitney test. As many participants showed no response, numerous points are at the limit of detection (100 SFC). Median ± interquartile range is displayed, but note that median values are at the limit of detection. The top interquartile range is visible in d. e Sum of IFNγ, IL-5, and IL-10 against the α-syn peptide pool as SFC per 106 cultured PBMC. Each point represents one participant. Gray circles, patients with AD (n = 38); open circles, controls (n = 41). Two-tailed Mann–Whitney test. As many participants showed no response, numerous points are at the limit of detection (100 SFC). Median ± interquartile range is plotted, but the median values are at the limit of detection. The top interquartile range is visible for HC.
Fig. 2 Reactivity to α-syn in patients with PD or AD as compared with HC. Magnitude of responses a IFNγ, b IL-5, c IL-10, and d sum of IFNγ, IL-5, and IL-10 against the α-syn peptide pool as SFC per 106 cultured PBMC. Each point represents one participant. Closed circles, patients with PD (n = 77); open circles, controls (n = 69). One-tailed Mann–Whitney test. As many participants showed no response, numerous points are at the limit of detection (100 SFC). Median ± interquartile range is displayed, but note that median values are at the limit of detection. The top interquartile range is visible in d. e Sum of IFNγ, IL-5, and IL-10 against the α-syn peptide pool as SFC per 106 cultured PBMC. Each point represents one participant. Gray circles, patients with AD (n = 38); open circles, controls (n = 41). Two-tailed Mann–Whitney test. As many participants showed no response, numerous points are at the limit of detection (100 SFC). Median ± interquartile range is plotted, but the median values are at the limit of detection. The top interquartile range is visible for HC.CC BY · PubMed Central
Fig. 3 Correlation between T cell reactivity and time since diagnosis. a Cohort 1 (n = 76 PD patients from UCSD, RUMC, LJI, and UAB), b Cohort 2 (n = 20 PD patients from UAB), c Cohorts 1 and 2 combined (n = 96 PD patients). The Y-axis shows the magnitude of responses (sum of IFNγ, IL-5, and IL-10) against the α-syn peptide pool as SFC per 106 cultured PBMC. The X-axis shows the years since PD diagnosis. Each point represents one donor. Because many participants showed no response, there are overlapping points at the limit of detection (100 SFC). Two-tailed Fisher’s exact test.
Fig. 3 Correlation between T cell reactivity and time since diagnosis. a Cohort 1 (n = 76 PD patients from UCSD, RUMC, LJI, and UAB), b Cohort 2 (n = 20 PD patients from UAB), c Cohorts 1 and 2 combined (n = 96 PD patients). The Y-axis shows the magnitude of responses (sum of IFNγ, IL-5, and IL-10) against the α-syn peptide pool as SFC per 106 cultured PBMC. The X-axis shows the years since PD diagnosis. Each point represents one donor. Because many participants showed no response, there are overlapping points at the limit of detection (100 SFC). Two-tailed Fisher’s exact test.CC BY · PubMed Central
Fig. 4 Correlation between individual cytokine responses and time since diagnosis. Cohorts 1 and 2 combined (n = 96 PD patients). The Y-axis shows the magnitude of responses a IFNγ, b IL-5, and c IL-10, against the α-syn peptide pool as SFC per 106 cultured PBMC. The X-axis shows the years since PD diagnosis. Each point represents one donor. Because many participants showed no response, there are overlapping points at the limit of detection (100 SFC). The number of patients in each quadrant is indicated in each graph. Two-tailed Fisher’s exact test.
Fig. 4 Correlation between individual cytokine responses and time since diagnosis. Cohorts 1 and 2 combined (n = 96 PD patients). The Y-axis shows the magnitude of responses a IFNγ, b IL-5, and c IL-10, against the α-syn peptide pool as SFC per 106 cultured PBMC. The X-axis shows the years since PD diagnosis. Each point represents one donor. Because many participants showed no response, there are overlapping points at the limit of detection (100 SFC). The number of patients in each quadrant is indicated in each graph. Two-tailed Fisher’s exact test.CC BY · PubMed Central
Fig. 5 IFNγ, IL-4, and IL-10 are produced by distinct T cells in response to α-syn. a–d After eliminating non-lymphocytes/monocytes and doublet cells by forward and side-scatter and dead cells by Live/Dead stain, cells were gated based on their cytokine expression and then cytokine-expressing cells were gated based on their CD3+ and CD56+ expression. CD3+ T cells were gated based on their CD4 and CD8 expression (CD8+, CD8+CD4+, CD4+, CD8−CD4−), and other populations based on CD3−CD56− and other markers as indicated; CD14−CD19+ (B cells), CD14+CD19− (Monocytes), CD14−CD19− (other) (Supplementary Fig. 5), and percentage live cells expressing cytokine from each of these were plotted. Samples with a frequency of cytokines below 0.02% of live lymphocytes after removal of background were excluded from this analysis. a IFNγ (n = 13), b IL-4 (n = 9), and c IL-10 (n = 6). Median ± interquartile range is indicated. d Boolean gating for combinations of cytokines shown as percentage of live cells, n = 20. Median ± interquartile range is indicated. The gating strategy is shown in Supplementary Fig. 5. e Plots were gated on IL-10+CD4+ T cells following negative control (DMSO) or α-syn stimulation. The gating strategy leading up to this step is shown in Supplementary Fig. 5. IL-10+ cells were then gated further on CD25 and CD127 expression (top row). Plots were gated on CD25+CD127loCD4+ T cells and then on IL-10 production (bottom row).
Fig. 5 IFNγ, IL-4, and IL-10 are produced by distinct T cells in response to α-syn. a–d After eliminating non-lymphocytes/monocytes and doublet cells by forward and side-scatter and dead cells by Live/Dead stain, cells were gated based on their cytokine expression and then cytokine-expressing cells were gated based on their CD3+ and CD56+ expression. CD3+ T cells were gated based on their CD4 and CD8 expression (CD8+, CD8+CD4+, CD4+, CD8−CD4−), and other populations based on CD3−CD56− and other markers as indicated; CD14−CD19+ (B cells), CD14+CD19− (Monocytes), CD14−CD19− (other) (Supplementary Fig. 5), and percentage live cells expressing cytokine from each of these were plotted. Samples with a frequency of cytokines below 0.02% of live lymphocytes after removal of background were excluded from this analysis. a IFNγ (n = 13), b IL-4 (n = 9), and c IL-10 (n = 6). Median ± interquartile range is indicated. d Boolean gating for combinations of cytokines shown as percentage of live cells, n = 20. Median ± interquartile range is indicated. The gating strategy is shown in Supplementary Fig. 5. e Plots were gated on IL-10+CD4+ T cells following negative control (DMSO) or α-syn stimulation. The gating strategy leading up to this step is shown in Supplementary Fig. 5. IL-10+ cells were then gated further on CD25 and CD127 expression (top row). Plots were gated on CD25+CD127loCD4+ T cells and then on IL-10 production (bottom row).CC BY · PubMed Central
Fig. 6 Correlation between α-syn-specific T cell reactivity and clinical variables. a Age (n = 97): dotted lines indicate 250 SFC and 70-year-old cut-off for two-tailed Fisher’s exact test. b Frequency and magnitude of T cell responses in males (n = 71) and females (n = 26) with PD. The dotted line indicates 250 SFC for Fisher’s exact test. c MoCA score (n = 85), d UPDRS score (n = 85), and e LED score (n = 86); dotted lines indicate 250 SFC and 1000 LED cut-off for two-tailed Fisher’s exact test. f Correlation between LED score and time since diagnosis (n = 86); dotted lines indicate 10 years since diagnosis and 1000 LED cut-off for two-tailed Fisher’s exact test. Correlation is indicated by Spearman r and associated p value. g Segregation of subjects with PD in low (<1000) and high (≥1000) LED score with diagnosis <10 and ≥10 years ago. Number of data points per condition is indicated in the figure (Total No.). Two-tailed Fisher’s exact test comparing individuals with <1000 LED, <10 years ago since diagnosis and >250 SFC (left in graph) vs. the three other groups. h Segregation of subjects with PD based on LED score (cut-off 1000), years since diagnosis (cut-off 10) and age (cut-off 70). Two-tailed Fisher’s exact test comparing individuals with <1000 LED, <10 years ago since diagnosis, >70 years old, and >250 SFC (left in graph) vs. the seven other groups. Total number of PD responding to α-syn peptide pool (n = 28). Total SFC is defined as the magnitude of responses (sum of IFNγ, IL-5, and IL-10) against the α-syn peptide pool as SFC per 106 cultured PBMC. b, g, h Median ± interquartile range is indicated.
Fig. 6 Correlation between α-syn-specific T cell reactivity and clinical variables. a Age (n = 97): dotted lines indicate 250 SFC and 70-year-old cut-off for two-tailed Fisher’s exact test. b Frequency and magnitude of T cell responses in males (n = 71) and females (n = 26) with PD. The dotted line indicates 250 SFC for Fisher’s exact test. c MoCA score (n = 85), d UPDRS score (n = 85), and e LED score (n = 86); dotted lines indicate 250 SFC and 1000 LED cut-off for two-tailed Fisher’s exact test. f Correlation between LED score and time since diagnosis (n = 86); dotted lines indicate 10 years since diagnosis and 1000 LED cut-off for two-tailed Fisher’s exact test. Correlation is indicated by Spearman r and associated p value. g Segregation of subjects with PD in low (<1000) and high (≥1000) LED score with diagnosis <10 and ≥10 years ago. Number of data points per condition is indicated in the figure (Total No.). Two-tailed Fisher’s exact test comparing individuals with <1000 LED, <10 years ago since diagnosis and >250 SFC (left in graph) vs. the three other groups. h Segregation of subjects with PD based on LED score (cut-off 1000), years since diagnosis (cut-off 10) and age (cut-off 70). Two-tailed Fisher’s exact test comparing individuals with <1000 LED, <10 years ago since diagnosis, >70 years old, and >250 SFC (left in graph) vs. the seven other groups. Total number of PD responding to α-syn peptide pool (n = 28). Total SFC is defined as the magnitude of responses (sum of IFNγ, IL-5, and IL-10) against the α-syn peptide pool as SFC per 106 cultured PBMC. b, g, h Median ± interquartile range is indicated.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

See all 387

Metadata

Authors
Lindestam Arlehamn, C. S., Dhanwani, R., Pham, J., Kuan, R., Frazier, A., Rezende Dutra, J., Phillips, E., Mallal, S., Roederer, M., Marder, K. S., Amara, A. W., Standaert, D. G., Goldman, J. G., Litvan, I., Peters, B., Sulzer, D., & Sette, A.
Affiliations
  • La Jolla Institute for Immunology (US)
  • Murdoch University (AU)
  • National Institutes of Health (US)
  • Columbia University Irving Medical Center (US)
  • University of Alabama at Birmingham (US)
  • Northwestern University (US)
  • University of California San Diego (US)
Corresponding author
  • Sulzer, David
  • Sette, Alessandro
Venue
Nature Communications
Published
2020-04-20
Volume
11
Issue
1
Pages
1875-1875
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3016458340
Cited by
386
References
40
Citations by year
2026: 33 · 2025: 59 · 2024: 72 · 2023: 70 · 2022: 82 · 2021: 54 · 2020: 15
FWCI
23.92
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Murdoch University Research Portal (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS095435, P50NS108675)
  • U.S. Department of Health & Human Services | NIH | National Institute on Aging (P50AG08702)
  • Parkinson's Foundation
  • Michael J. Fox Foundation for Parkinson's Research
  • UCSD-LJI Program in Immunology
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords
alpha-synuclein, T cell response, Parkinson's disease, early diagnosis, autoimmunity, levodopa equivalent daily dose, pathogenesis
MeSH terms
Aged, Aged, 80 and over, Female, Humans, Levodopa, Longitudinal Studies, Male, Middle Aged, Neurons, Parkinson Disease, T-Lymphocytes, Cytokines, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease. https://app.cochat.ai/papers/10.1038/s41467-020-15626-w
The paper
Lindestam Arlehamn, C. S., Dhanwani, R., Pham, J., Kuan, R., Frazier, A., Rezende Dutra, J., Phillips, E., Mallal, S., Roederer, M., Marder, K. S., Amara, A. W., Standaert, D. G., Goldman, J. G., Litvan, I., Peters, B., Sulzer, D., & Sette, A. (2020). α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease. Nature Communications. https://doi.org/10.1038/s41467-020-15626-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.